Irrimax Corporation
Carlos Alonso serves as the Chairman of the Board at both Irrimax Corporation and Suanfarma, and holds the position of Executive Chairman of the Board at Cardioline. Additionally, Carlos Alonso is a Partner and Operating Partner at ARCHIMED, and a Board Member at HONEXT®️. Educational background includes a Master's degree in Management from IESE Business School in 1993 and a program completed at INSEAD in 2020.
This person is not in any teams
This person is not in any offices
Irrimax Corporation
Irrimax Corporation is focused on treating and preventing infections, reducing healthcare costs, improving patient outcomes and increasing the safety of healthcare professionals.Innovation Technologies, Inc., parent company to Irrimax Corporation, holds the rights to US and worldwide patents that provide broad protection for the use oflow-concentration CHG (1% or less) technology. The company’s flagship product, Irrisept, is jet lavage containing low concentration Chlorhexidine Gluconate (CHG) 0.05% in sterile water for irrigation.Irrimax has attracted experts in the fields of product development, clinical research, manufacturing and distribution. Their management team is committed to leading the organization according to high standards of integrity and accountability. Irrimax Corporation is focused on driving innovation and improving patient outcomes.